Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Fiche du document
2016
- doi: 10.1186/s12879-016-1658-0
- issn: 1471-2334
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12879-016-1658-0
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/27391967
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1471-2334
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_F0F12B5AC40F6
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Coats of arms Devices Arms, Coats of Heraldic devicesCiter ce document
D. Héquet et al., « Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections. », Serveur académique Lausannois, ID : 10.1186/s12879-016-1658-0
Métriques
Partage / Export
Résumé
BACKGROUND: Ventricular assist devices (VAD) are valuable options for patients with heart failure awaiting cardiac transplantation. We assessed the impact of pre-transplant VAD implantation on the incidence of post-transplant infections in a nationwide cohort of heart transplant recipients. METHODS: Heart transplant recipients included in the Swiss Transplant Cohort Study between May 2008 and December 2012 were analyzed. Cumulative incidence curves were used to calculate the incidence of bacterial or Candida infections (primary endpoint) and of other infections (secondary endpoint) after transplant. Cox regression models treating death as a competing risk were used to identify risk factors for the development of infection after transplant. RESULTS: Overall, 119 patients were included in the study, 35 with a VAD and 84 without VAD. Cumulative incidences of post-transplant bacterial or Candida infections were 37.7 % in VAD patients and 40.4 % in non-VAD patients. In multivariate analysis, the use of cotrimoxazole prophylaxis was the only variable associated with bacterial/Candida infections after transplant (HR 0.29 [95 % CI 0.15-0.57], p